DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aurobindo Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 5 hrs ago·6 Aug 2026, 12:38 pm

Aurobindo Pharma

Aurobindo Pharma has announced its participation in an upcoming investor and analyst conference scheduled for August 11 to 13, 2026. The company's management is expected to engage with institutional investors and analysts during this event to discuss the firm's business strategy and future outlook.

This participation is a routine corporate communication that signals the company's openness to dialogue with the investment community. For investors, such events provide a platform to gain direct insights into management's perspective on market trends and operational plans.

Investors should watch for any specific guidance or commentary regarding the company's growth trajectory, product pipeline, or financial targets that may be shared during the discussions.